Predictive Nomograms for Assessing Axillary Lymph Node Metastasis in Patients with Breast Cancer - Takeaways - MDSpire

Predictive Nomograms for Assessing Axillary Lymph Node Metastasis in Patients with Breast Cancer

  • By

  • Zixi Deng

  • Yuechong Li

  • Yongchao Luo

  • Xi Cao

  • Songjie Shen

  • November 26, 2025

  • 0 min

Share

  • 1

    Axillary lymph node metastasis (ALNM) is crucial for breast cancer prognosis and influences treatment decisions.

  • 2

    Sentinel lymph node biopsy (SLNB) is less invasive than axillary lymph node dissection (ALND) and can replace ALND in certain patients.

  • 3

    Preoperative axillary ultrasound is commonly used but has limitations in accurately assessing nodal tumor burden.

  • 4

    Fluorodeoxyglucose PET/CT shows high specificity for detecting metastatic axillary lymph nodes but may underestimate their number.

  • 5

    This study developed predictive models using ultrasound and PET/CT data to assess ALNM risk and guide treatment for early-stage breast cancer patients.

Original Source(s)

Predictive Nomograms for Assessing Axillary Lymph Node Metastasis in Patients with Breast Cancer

  • by Zixi Deng, Yuechong Li, Yongchao Luo, Xi Cao, Songjie Shen

  • November 26, 2025

Related Content

Research progress in imaging detection of brain metastases

Dynamic changes and clinical significance of the gut microbiota and serum metabolites in breast cancer onset, progression and chemotherapy intervention

Management of toxicities from antibody – drug conjugates in breast cancer